Executive Chairman, GTx, Inc.
Robert Wills, Ph.D. has over three decades of experience as a leader in the pharmaceutical industry. Dr Wills is currently serves as the Executive Chairman of GTx, Inc., Chairman of the Board of CymaBay Therapeutics, Board member at Parion Sciences, Inc., and a member of the Emerging Companies Section Governing Board of Biotechnology Innovation Organization (BIO). Prior to these roles, Rob spent over 25 years at Johnson & Johnson. Most recently he was Vice President, Alliance Management, Janssen Pharmaceutical Companies of Johnson & Johnson. He also served as Senior Vice President Global Development, where he was responsible for the R&D pipeline and a member of the R&D Board of Directors. In addition he served on several of the commercial Operating Company Boards and key pharmaceutical group decision-making committees. Rob began his career at Hoffmann-LaRoche where he spent 10 years in several roles of scientific responsibility. He holds a B.S. in Biochemistry and an M.S. in Pharmaceutics from the University of Wisconsin and a PhD in Pharmaceutics from the University of Texas.